How a Lumbar Rhizotomy Procedure Can Reduce Chronic Back Pain
This is not a replacement for medical care and is intended exclusively for educational purposes. The content provided here does not constitute medical guidance. If you’re experiencing any of these symptoms, we strongly recommend you consult a qualified healthcare provider.
Low back pain is the leading cause of disability worldwide, affecting hundreds of millions of people and generating a substantial share of global healthcare expenditure (GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, The Lancet, 201832154-2). For a significant proportion of chronic lumbar pain patients – estimates suggest 15-45% – the source is not a herniated disc or compressed nerve root, but the small joints connecting adjacent vertebrae: the facet joints. These joints do not respond to treatments designed for disc-based pain, and for many patients, lasting relief requires a procedure specifically designed for this anatomy: lumbar rhizotomy.
Also known as radiofrequency neurotomy (RFN) or medial branch neurotomy, this minimally invasive intervention disrupts the small nerves carrying pain signals from the facet joints to the brain. By targeting these pathways precisely, RFN can produce meaningful and durable pain relief in appropriately selected patients, without the risks and recovery demands of open surgery.
Understanding what lumbar rhizotomy is, who benefits, what recovery involves, and what the evidence shows helps patients and clinicians make informed decisions within the broader landscape of chronic back pain care.
Ready to talk to
a specialist?
Skip the wait, the paperwork, and the referrals.
A certified specialist is ready to see you.
What Is a Lumbar Rhizotomy?
The term “rhizotomy” derives from the Greek for root and cutting. In modern clinical practice for spinal pain, RFN refers to radiofrequency ablation of the medial branch nerves – the small sensory branches that carry nociceptive signals from the facet joints.
Each lumbar facet joint is supplied by two medial branches: one from the same spinal level and one from the level above. To adequately denervate a single joint, both must be targeted. Most RFN procedures address two to four levels simultaneously, meaning four to eight nerve branches may be treated in a single session.
The underlying rationale was established through anatomical research by Bogduk and colleagues and refined through decades of subsequent clinical work. Radiofrequency energy delivered through a precisely placed needle heats the target nerve to 80–90°C for 60–90 seconds per lesion. The nerve is not permanently destroyed; medial branches typically regenerate over 6–18 months, at which point pain may return and re-treatment may be considered.

How the Lumbar Rhizotomy Procedure Works
The procedure is performed on an outpatient basis in a fluoroscopy suite or interventional radiology setting. The patient lies face-down, and the skin overlying the target area is prepared and draped. Live X-ray fluoroscopy guides needle placement throughout.
Step-by-step overview of the RFN session:
- Skin anesthesia – local anesthetic is applied at each needle entry site
- Needle placement – a radiofrequency cannula is advanced under fluoroscopic guidance to the junction of the superior articular process and transverse process – the anatomical landmark for the medial branch nerve
- Stimulation testing – electrical stimulation confirms proximity to the target nerve (concordant sensory response) and rules out unintended motor involvement
- Radiofrequency ablation – current at 80–90°C for 60–90 seconds creates a small thermal lesion around the needle tip
- Repetition – the process is repeated at each target level
The full session typically takes 45–90 minutes. Patients are monitored briefly and discharged the same day. Most are advised to avoid strenuous activity for 24–48 hours.
Dreyfuss and colleagues demonstrated the anatomical accuracy and clinical efficacy of this approach in a landmark prospective study: 87% of patients who achieved adequate diagnostic block response also achieved significant pain relief at 12 months (Dreyfuss et al., Spine, 2000).
Who Is a Candidate?
Patient selection is the most important determinant of outcomes. RFN is designed specifically for facet joint-mediated pain, and only patients in whom this pain source has been confirmed through diagnostic blocks should be considered.
The standard selection pathway involves two rounds of diagnostic medial branch blocks – small volumes of local anesthetic injected at the target nerves under fluoroscopic guidance. A patient is generally considered a candidate when blocks produce at least 50–80% temporary pain relief, confirming that the targeted nerves meaningfully contribute to their pain (Manchikanti et al., Pain Physician, 2015).
Typical candidate profile:
- Chronic axial low back pain for ≥3–6 months
- Pain worsened by spinal extension, rotation, or lateral bending
- No structural pathology requiring surgical correction (significant disc herniation, instability, fracture)
- Adequate prior trial of conservative management
- Positive response to diagnostic medial branch blocks
Facet joint pain prevalence increases with age, making this population particularly relevant for middle-aged and older adults. RFN is also applicable following spinal fusion, where adjacent segment joints may develop accelerated degenerative changes.
Lumbar Rhizotomy Recovery Time and What to Expect
Recovery time follows a predictable pattern that patients benefit from understanding before the session. The most important feature is a post-procedural pain flare – a temporary increase in soreness and stiffness at the treated levels – occurring in the first one to two weeks.
This flare is a normal tissue response to the thermal lesion. Patients are typically advised to:
- Expect localized soreness and muscle spasm for 7–14 days
- Use NSAIDs or acetaminophen for comfort during the flare
- Apply ice to the treated area in the first 48 hours
- Resume light activity within a day or two, avoiding heavy exertion for one to two weeks
- Understand that meaningful relief may not emerge until the flare resolves – typically 4–6 weeks post-procedure
For patients who respond well, functional improvement is generally apparent within 4–8 weeks. Pain relief, when achieved, typically persists 6–12 months or longer before potential nerve regeneration warrants reassessment. Re-treatment when pain returns produces comparable relief in most cases.
What the Evidence Shows

The evidence base spans randomized controlled trials, systematic reviews, and long-term observational data, with outcomes generally favorable in appropriately selected patients.
In a randomized, sham-controlled trial, Van Kleef and colleagues demonstrated that radiofrequency lumbar facet neurotomy produced significantly greater reductions in pain and functional improvement at eight weeks versus sham in patients with confirmed facet joint pain (Van Kleef et al., Spine, 1999).
For duration of effect, the landmark RCT by Lord and colleagues – examining cervical radiofrequency neurotomy but establishing conceptual foundations widely applied to lumbar practice – showed that correct technique on confirmed targets can produce relief lasting more than a year, with re-treatment producing comparable outcomes (Lord et al., N Engl J Med, 1996).
Systematic reviews by Manchikanti and colleagues concluded that lumbar medial branch RFN has good evidence of effectiveness for facet joint pain when appropriate patient selection criteria – including confirmed diagnostic block response – are applied (Manchikanti et al., Pain Physician, 2015).
Risks and Limitations
RFN is a low-risk outpatient procedure with a safety profile substantially more favorable than surgical alternatives. The most common adverse event is the post-procedural flare described above – temporary and self-limiting.
Rarer complications include:
- Infection – uncommon with proper sterile technique
- Neuritis – nerve inflammation producing burning or shooting pain; typically self-limiting
- Skin sensory changes – minor hypersensitivity or numbness over treated area
Importantly, RFN does not address the underlying degenerative process in the facet joints, and pain may recur when nerve regeneration occurs. It is best understood as one component of a broader pain management and rehabilitation strategy rather than a standalone cure.
Advanced Diagnostics and Regenerative Approaches to Chronic Pain
For patients managing chronic back pain, the quality of initial diagnostic evaluation significantly shapes treatment decisions. Identifying the precise source – facet joint, disc, sacroiliac joint, myofascial – determines whether RFN, injection therapy, or another intervention is most appropriate.
UberDoc is a direct-pay platform providing fast, direct access to top specialists for a single, transparent price – no insurance delays or referral requirements, with both in-person and telehealth appointments available. For patients exploring evidence-based options for chronic back pain – including RFNand regenerative medicine – direct access to the right specialist, without referral bottlenecks, supports faster, more personalized care decisions.

Key Takeaways
- Lumbar rhizotomy – also called radiofrequency neurotomy (RFN) – is a minimally invasive outpatient procedure that ablates the medial branch nerves supplying lumbar facet joints to interrupt chronic pain signals
- The lumbar rhizotomy procedure takes 45–90 minutes under fluoroscopic guidance and is done on a same-day basis
- Patient selection through diagnostic medial branch blocks is critical: candidates must demonstrate ≥50–80% temporary relief from blocks before proceeding
- Lumbar rhizotomy recovery time involves a post-procedural soreness flare lasting 1–2 weeks, with meaningful relief typically emerging within 4–8 weeks
- Duration of effect is generally 6–12 months before potential nerve regeneration; re-treatment produces comparable outcomes
- RCT and systematic review evidence supports this procedure for appropriately selected patients with confirmed facet joint pain
Frequently Asked Questions
The procedure thermally ablates the medial branch nerves supplying the facet joints. Unlike surgery, it does not remove or decompress structures; unlike steroid injections, it targets nerve function rather than inflammation. It is specifically designed for facet joint pain and is not appropriate for disc herniation, nerve root compression, or instability.
For most responders, relief lasts 6–12 months, though some experience longer duration. Because medial branch nerves can regenerate over time, pain may gradually return. Re-treatment with a repeat procedure typically produces comparable relief, making RFN a repeatable long-term management option for appropriate candidates.
Recovery involves a post-procedural soreness flare at the treated sites for the first 1–2 weeks. This is a normal tissue response and does not indicate failure. Light activity can resume within a day or two; full activity within one to two weeks. Meaningful pain reduction typically becomes apparent 4–8 weeks after the procedure.
Good candidates have chronic axial low back pain not responding to conservative management, with confirmed facet joint involvement through positive diagnostic medial branch blocks. Patients with structural pathology requiring surgical correction, active infection, or pain not attributable to facet joints are generally not candidates.
Yes. In the context of spinal pain, RFN refers to radiofrequency ablation (RFA) of the medial branch nerves. “Rhizotomy” denotes nerve disruption, while “radiofrequency neurotomy” describes the thermal mechanism. These terms are used interchangeably in clinical practice.
The most common side effect is a temporary post-procedural pain flare lasting one to two weeks. Rarer complications include localized neuritis, minor sensory changes over the treated skin, and infection (uncommon with sterile technique). RFN does not address the degenerative cause of facet disease, and pain may recur with nerve regeneration.
References
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. “Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017.” The Lancet. 2018;392(10159):1789–1858. https://doi.org/10.1016/S0140-6736(17)32154-232154-2)
- Dreyfuss P, Halbrook B, Pauza K, Joshi A, McLarty J, Bogduk N. “Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain.” Spine. 2000;25(10):1270–1277. https://doi.org/10.1097/00007632-200005150-00012
- Van Kleef M, Barendse GA, Kessels A, Voets HM, Weber WE, de Lange S. “Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain.” Spine. 1999;24(18):1937–1942. https://doi.org/10.1097/00007632-199909150-00013
- Lord SM, Barnsley L, Wallis BJ, McDonald GJ, Bogduk N. “Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain.” N Engl J Med. 1996;335(23):1721–1726. https://doi.org/10.1056/NEJM199612053352302
- Manchikanti L, Kaye AD, Boswell MV, et al. “A systematic review and best evidence synthesis of the effectiveness of therapeutic facet joint interventions in managing chronic spinal pain.” Pain Physician. 2015;18(4):E535–E582. https://pubmed.ncbi.nlm.nih.gov/26056101/
- Manchikanti L, Abdi S, Atluri S, et al. “An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II.” Pain Physician. 2013;16(2 Suppl):S49–S283. https://pubmed.ncbi.nlm.nih.gov/23615883/
- Boswell MV, Colson JD, Sehgal N, Dunbar EE, Epter R. “A systematic review of therapeutic facet joint interventions in chronic spinal pain.” Pain Physician. 2007;10(1):229–253. https://pubmed.ncbi.nlm.nih.gov/17256032/
- Leclaire R, Fortin L, Lambert R, Bergeron YM, Rossignol M. “Radiofrequency facet joint denervation in the treatment of low back pain: a placebo-controlled clinical trial to assess efficacy.” Spine. 2001;26(13):1411–1416. https://doi.org/10.1097/00007632-200107010-00011